NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW

Detalhes bibliográficos
Autor(a) principal: Gruber , Cristiane Regina
Data de Publicação: 2024
Outros Autores: Giovanini , Allan Fernando, Skare, Thelma, Rastelli , Graziela Junges Crescente, Kubrusly , Luiz Fernando, Sigwalt , Marcos Fabiano, Tabushi , Fernando Issamu, Manso , Jose Eduardo Ferreira, Possiedi , Rafael Dib
Tipo de documento: preprint
Idioma: por
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/7766
Resumo: Introduction: Non-melanoma skin cancer (NMSC) comprises a group of neoplasms with a high incidence in the world population. It is divided into basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). As it is highly prevalent, understanding the process of oncogenesis and the relationship with ions, proteins and cellular receptors in CPMN can contribute to the evaluation of new therapies. Objective: To understand the oncogenesis process of non-melanoma skin tumors and its relationship with the immunolocalization of IP3R. Method: Integrative literature review with evidence synthesis. The database was PUBMED; the search strategy: “squamous cell carcinoma, AND/OR basal cell carcinoma, AND/OR IP3R, AND/OR immunohistochemistry”. Works published between 2018 and 2023 were considered for review; 40 works were included, fully read and summarized. Results: NMSC is the most common malignant tumor worldwide, with 75-80% being BCC, and up to 25% being SCC. Molecular interactions in general involve a large participation of tumor suppressor molecules, as well as procto-oncogenes. Furthermore, voltage-dependent ion channels control the cytosolic flow of ions, including calcium. The IP3R (phosphatidyl inositol-3 receptor) allows the exit of calcium from the endoplasmic reticulum so that it can be used by the cell for physiological activities such as proliferation, angiogenesis, motility and invasion capacity. Conclusion: The IP3R, due to its immunohistochemical expression characteristics, appears may also be related to the pathophysiology of NMSC.
id SCI-1_c009198ae8f6764d0e9c0236dc5fa042
oai_identifier_str oai:ops.preprints.scielo.org:preprint/7766
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEWCANCER DE PELE NÃO MELANOMA: REVISÃO INTEGRATIVACarcinoma espinocelularCarcinoma basocelularIP3RImunoistoquímicaSquamous cell carcinomaIP3RImmunohistochemistryIntroduction: Non-melanoma skin cancer (NMSC) comprises a group of neoplasms with a high incidence in the world population. It is divided into basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). As it is highly prevalent, understanding the process of oncogenesis and the relationship with ions, proteins and cellular receptors in CPMN can contribute to the evaluation of new therapies. Objective: To understand the oncogenesis process of non-melanoma skin tumors and its relationship with the immunolocalization of IP3R. Method: Integrative literature review with evidence synthesis. The database was PUBMED; the search strategy: “squamous cell carcinoma, AND/OR basal cell carcinoma, AND/OR IP3R, AND/OR immunohistochemistry”. Works published between 2018 and 2023 were considered for review; 40 works were included, fully read and summarized. Results: NMSC is the most common malignant tumor worldwide, with 75-80% being BCC, and up to 25% being SCC. Molecular interactions in general involve a large participation of tumor suppressor molecules, as well as procto-oncogenes. Furthermore, voltage-dependent ion channels control the cytosolic flow of ions, including calcium. The IP3R (phosphatidyl inositol-3 receptor) allows the exit of calcium from the endoplasmic reticulum so that it can be used by the cell for physiological activities such as proliferation, angiogenesis, motility and invasion capacity. Conclusion: The IP3R, due to its immunohistochemical expression characteristics, appears may also be related to the pathophysiology of NMSC.Introdução: O câncer de pele não melanoma (CPNM) compeende grupo de neoplasias com alta incidência na população mundial. É dividido em carcinoma basocelular (CBC) e de células escamosas (CEC). Por ser de grande prevalência, entender o processo de oncogênese e a relação com íons, proteínas e receptores celulares no CPMN pode contribuir para que novas terapêuticas sejam avaliadas. Objetivo: Entender o processo da oncogênese dos tumores de pele não melanomas e sua relação com a imunolocalização do IP3R. Método: Revisão integrativa da literatura com síntese de evidências. A base de dados foi o PUBMED; a  estratégia de busca: “carcinoma espinocelular, AND/OR carcinoma basocelular, AND/OR IP3R, AND/OR imunoistoquímica”. Foram considerados para revisão os trabalhos publicados entre 2018 e 2023. Foram incluídos 40 trabalhos, integralmente lidos e resumidos. Resultados: CPNMs são os tumores malignos mais comuns em todo o mundo, sendo 75-80% o CBC, e até 25% o CEC. As interações moleculares de forma geral, envolvem grande participação de moléculas supressoras tumorais, assim como de procto-oncogenes. Além disso, canais iônicos voltagem dependente controlam o fluxo citosólico de íons, dentre eles o cálcio. O IP3R (receptor do fosfatidil inositol-3) permite a saída de cálcio do retículo endoplasmático para que seja utilizado pela célula para atividades fisiológias como proliferação, angiogênese, motilidade e capacidade de invasão. Conclusão: O IP3R, pelas características de expressão imunoistoquímica, parece estar relacionado também, à fisiopatologia do CPNM.SciELO PreprintsSciELO PreprintsSciELO Preprints2024-01-04info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/776610.1590/SciELOPreprints.7766porhttps://preprints.scielo.org/index.php/scielo/article/view/7766/14506Copyright (c) 2024 Cristiane Regina Gruber , Allan Fernando Giovanini , Thelma Larocca Skare, Graziela Junges Crescente Rastelli , Luiz Fernando Kubrusly , Marcos Fabiano Sigwalt , Fernando Issamu Tabushi , Jose Eduardo Ferreira Manso , Rafael Dib Possiedi https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGruber , Cristiane ReginaGiovanini , Allan FernandoSkare, ThelmaRastelli , Graziela Junges CrescenteKubrusly , Luiz FernandoSigwalt , Marcos FabianoTabushi , Fernando IssamuManso , Jose Eduardo FerreiraPossiedi , Rafael Dibreponame:SciELO Preprintsinstname:Scientific Electronic Library Online (SCIELO)instacron:SCI2023-12-20T11:56:35Zoai:ops.preprints.scielo.org:preprint/7766Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2023-12-20T11:56:35SciELO Preprints - Scientific Electronic Library Online (SCIELO)false
dc.title.none.fl_str_mv NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
CANCER DE PELE NÃO MELANOMA: REVISÃO INTEGRATIVA
title NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
spellingShingle NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
Gruber , Cristiane Regina
Carcinoma espinocelular
Carcinoma basocelular
IP3R
Imunoistoquímica
Squamous cell carcinoma
IP3R
Immunohistochemistry
title_short NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
title_full NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
title_fullStr NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
title_full_unstemmed NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
title_sort NON-MELANOMA SKIN CANCER: AN INTEGRATIVE REVIEW
author Gruber , Cristiane Regina
author_facet Gruber , Cristiane Regina
Giovanini , Allan Fernando
Skare, Thelma
Rastelli , Graziela Junges Crescente
Kubrusly , Luiz Fernando
Sigwalt , Marcos Fabiano
Tabushi , Fernando Issamu
Manso , Jose Eduardo Ferreira
Possiedi , Rafael Dib
author_role author
author2 Giovanini , Allan Fernando
Skare, Thelma
Rastelli , Graziela Junges Crescente
Kubrusly , Luiz Fernando
Sigwalt , Marcos Fabiano
Tabushi , Fernando Issamu
Manso , Jose Eduardo Ferreira
Possiedi , Rafael Dib
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gruber , Cristiane Regina
Giovanini , Allan Fernando
Skare, Thelma
Rastelli , Graziela Junges Crescente
Kubrusly , Luiz Fernando
Sigwalt , Marcos Fabiano
Tabushi , Fernando Issamu
Manso , Jose Eduardo Ferreira
Possiedi , Rafael Dib
dc.subject.por.fl_str_mv Carcinoma espinocelular
Carcinoma basocelular
IP3R
Imunoistoquímica
Squamous cell carcinoma
IP3R
Immunohistochemistry
topic Carcinoma espinocelular
Carcinoma basocelular
IP3R
Imunoistoquímica
Squamous cell carcinoma
IP3R
Immunohistochemistry
description Introduction: Non-melanoma skin cancer (NMSC) comprises a group of neoplasms with a high incidence in the world population. It is divided into basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). As it is highly prevalent, understanding the process of oncogenesis and the relationship with ions, proteins and cellular receptors in CPMN can contribute to the evaluation of new therapies. Objective: To understand the oncogenesis process of non-melanoma skin tumors and its relationship with the immunolocalization of IP3R. Method: Integrative literature review with evidence synthesis. The database was PUBMED; the search strategy: “squamous cell carcinoma, AND/OR basal cell carcinoma, AND/OR IP3R, AND/OR immunohistochemistry”. Works published between 2018 and 2023 were considered for review; 40 works were included, fully read and summarized. Results: NMSC is the most common malignant tumor worldwide, with 75-80% being BCC, and up to 25% being SCC. Molecular interactions in general involve a large participation of tumor suppressor molecules, as well as procto-oncogenes. Furthermore, voltage-dependent ion channels control the cytosolic flow of ions, including calcium. The IP3R (phosphatidyl inositol-3 receptor) allows the exit of calcium from the endoplasmic reticulum so that it can be used by the cell for physiological activities such as proliferation, angiogenesis, motility and invasion capacity. Conclusion: The IP3R, due to its immunohistochemical expression characteristics, appears may also be related to the pathophysiology of NMSC.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/7766
10.1590/SciELOPreprints.7766
url https://preprints.scielo.org/index.php/scielo/preprint/view/7766
identifier_str_mv 10.1590/SciELOPreprints.7766
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/7766/14506
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:Scientific Electronic Library Online (SCIELO)
instacron:SCI
instname_str Scientific Electronic Library Online (SCIELO)
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - Scientific Electronic Library Online (SCIELO)
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047814661865472